Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1947 2
1948 4
1949 2
1950 6
1951 29
1952 45
1953 41
1954 44
1955 45
1956 20
1957 21
1958 15
1959 16
1960 35
1961 28
1962 31
1963 76
1964 205
1965 105
1966 133
1967 187
1968 279
1969 301
1970 386
1971 447
1972 497
1973 602
1974 655
1975 713
1976 734
1977 740
1978 810
1979 883
1980 1008
1981 1011
1982 1213
1983 1472
1984 1717
1985 2088
1986 2089
1987 2362
1988 2616
1989 2954
1990 3356
1991 3428
1992 3620
1993 4009
1994 4138
1995 4322
1996 4591
1997 4617
1998 4880
1999 5074
2000 5804
2001 6122
2002 6579
2003 7124
2004 7752
2005 8191
2006 8951
2007 9301
2008 9677
2009 10327
2010 11382
2011 12166
2012 12957
2013 13069
2014 14032
2015 14841
2016 14393
2017 13976
2018 14058
2019 14363
2020 14918
2021 14846
2022 14134
2023 13130
2024 13904
2025 14622
2026 8735
2027 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

344,164 results

Results by year

Filters applied: . Clear all
Page 1
The future of peptides in cancer treatment.
Kurrikoff K, Aphkhazava D, Langel Ü. Kurrikoff K, et al. Curr Opin Pharmacol. 2019 Aug;47:27-32. doi: 10.1016/j.coph.2019.01.008. Epub 2019 Mar 8. Curr Opin Pharmacol. 2019. PMID: 30856511 Review.
Peptides hold great potential for the cancer therapy and diagnostics. In the current review, the main and most influential areas of peptide cancer therapeutics are overviewed. These include the development of anticancer peptides, u …
Peptides hold great potential for the cancer therapy and diagnostics. In the current review, the main and most influent …
Advancements in therapeutic peptides: Shaping the future of cancer treatment.
Chen X, Zhao Z, Laster KV, Liu K, Dong Z. Chen X, et al. Biochim Biophys Acta Rev Cancer. 2024 Nov;1879(6):189197. doi: 10.1016/j.bbcan.2024.189197. Epub 2024 Oct 14. Biochim Biophys Acta Rev Cancer. 2024. PMID: 39413854 Free article. Review.
In the evolving landscape of cancer treatment, therapeutic peptides are assuming to play an increasingly vital role. Although the number of peptide drugs available for clinical cancer treatment is currently limited, extensive preclinical …
In the evolving landscape of cancer treatment, therapeutic peptides are assuming to play an increasingly vital role. Al …
Self-Assembly of Peptides as an Alluring Approach toward Cancer Treatment and Imaging.
Ghafoor MH, Song BL, Zhou L, Qiao ZY, Wang H. Ghafoor MH, et al. ACS Biomater Sci Eng. 2024 May 13;10(5):2841-2862. doi: 10.1021/acsbiomaterials.4c00491. Epub 2024 Apr 22. ACS Biomater Sci Eng. 2024. PMID: 38644736 Review.
This review highlights the alluring properties, configurations, and self-assembly of peptide molecules which benefit the traditional approach toward cancer therapy while sparing the healthy cells in the process. As targeted drug delivery systems, self-assembl …
This review highlights the alluring properties, configurations, and self-assembly of peptide molecules which benefit the traditional …
Biomimetic Peptides for the Treatment of Cancer.
Mine Y, Munir H, Nakanishi Y, Sugiyama D. Mine Y, et al. Anticancer Res. 2016 Jul;36(7):3565-70. Anticancer Res. 2016. PMID: 27354624 Review.
Cancer remains one of the leading causes of death worldwide, indicating that current cancer therapies are ineffective. Therefore, new treatments with high specificity and low toxicity are needed. Cancerous cells can be distinguished from normal cells b …
Cancer remains one of the leading causes of death worldwide, indicating that current cancer therapies are ineffective. Therefo …
The Potential Use of Peptides in Cancer Treatment.
Yavari B, Mahjub R, Saidijam M, Raigani M, Soleimani M. Yavari B, et al. Curr Protein Pept Sci. 2018;19(8):759-770. doi: 10.2174/1389203719666180111150008. Curr Protein Pept Sci. 2018. PMID: 29332577 Review.
For example, tumors may develop resistance, cancers may relapse after treatment, and the drugs may induce secondary malignancies in the treatment of metastatic cancer. ...This review highlights recent advances in and future prospects for the applicatio …
For example, tumors may develop resistance, cancers may relapse after treatment, and the drugs may induce secondary malignanci …
An Overview of Drug Delivery Systems.
Jain KK. Jain KK. Methods Mol Biol. 2020;2059:1-54. doi: 10.1007/978-1-4939-9798-5_1. Methods Mol Biol. 2020. PMID: 31435914 Review.
There has been a considerable increase in the number of new biotechnology-based therapeutics. Most of these are proteins and peptides, and their delivery present special challenges. ...Most of the advances in targeted drug delivery have occurred in therapy of …
There has been a considerable increase in the number of new biotechnology-based therapeutics. Most of these are proteins and pepti …
Peptide-drug conjugates: A new paradigm for targeted cancer therapy.
Wang M, Liu J, Xia M, Yin L, Zhang L, Liu X, Cheng Y. Wang M, et al. Eur J Med Chem. 2024 Feb 5;265:116119. doi: 10.1016/j.ejmech.2023.116119. Epub 2024 Jan 1. Eur J Med Chem. 2024. PMID: 38194773 Review.
Peptide-drug conjugates (PDCs) are the new hope for targeted therapy after antibody-drug conjugates (ADCs). ...Two PDCs have been approved by the US Food and Drug Administration (FDA) for the treatment of cancer. The therapeutic effects of PDCs are rem …
Peptide-drug conjugates (PDCs) are the new hope for targeted therapy after antibody-drug conjugates (ADCs). ...Two PDCs have b …
Peptide-Drug Conjugates: A New Hope for Cancer.
Armstrong A, Coburn F, Nsereko Y, Al Musaimi O. Armstrong A, et al. J Pept Sci. 2025 Aug;31(8):e70040. doi: 10.1002/psc.70040. J Pept Sci. 2025. PMID: 40646707 Free PMC article. Review.
Peptide-drug conjugates (PDCs) are advancing as targeted cancer therapies, leveraging lessons from antibody-drug conjugates (ADCs) to improve tumour specificity. ...By refining targeting precision and payload delivery, next-generation PDCs may expand treatment …
Peptide-drug conjugates (PDCs) are advancing as targeted cancer therapies, leveraging lessons from antibody-drug conjugates (A …
Bioactive Peptides as Therapeutic Adjuvants for Cancer.
Quintal-Bojórquez N, Segura-Campos MR. Quintal-Bojórquez N, et al. Nutr Cancer. 2021;73(8):1309-1321. doi: 10.1080/01635581.2020.1813316. Epub 2020 Aug 31. Nutr Cancer. 2021. PMID: 32865023 Review.
Among the broad spectrum of complementary medicine, bioactive peptides from natural sources have gained great interest due to their potential use in the treatment of chronical diseases such as cancer. ...However, there is absence of formal pharmacokinetic pro …
Among the broad spectrum of complementary medicine, bioactive peptides from natural sources have gained great interest due to their p …
Peptide-Based Treatment: A Promising Cancer Therapy.
Xiao YF, Jie MM, Li BS, Hu CJ, Xie R, Tang B, Yang SM. Xiao YF, et al. J Immunol Res. 2015;2015:761820. doi: 10.1155/2015/761820. Epub 2015 Oct 19. J Immunol Res. 2015. PMID: 26568964 Free PMC article. Review.
In treating cancer, peptide-based chemotherapy can be mainly divided into three types, peptide-alone therapy, peptide vaccines, and peptide-conjugated nanomaterials. ...In this review, we mainly focus on the new advances in the applicatio …
In treating cancer, peptide-based chemotherapy can be mainly divided into three types, peptide-alone therapy, …
344,164 results
You have reached the last available page of results. Please see the User Guide for more information.